Q2 2013 Holdings
Filed 2013-07-31 | 60 holdings | $50.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Idec, Inc.(BIIB) | Common | 09062X103 | $41.3M | 191,983 | 82.0% |
| Accuray, Inc.(ARAY) | Common | 004397105 | $4.2M | 731,943 | 8.3% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $4.2M | 75,000 | 8.3% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $77.1K | 1,504,712 | 0.2% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $62.9K | 279,759 | 0.1% |
| Celgene Corporation(CELG) | Common | 151020104 | $59.6K | 510,046 | 0.1% |
| Vertex Pharmaceuticals, Inc.(VRTX) | Common | 92532F100 | $36.3K | 454,164 | 0.1% |
| Alexion Pharmaceuticals, Inc.(ALXN) | Common | 015351109 | $34.3K | 371,329 | 0.1% |
| Puma Biotechnology, Inc.(PBYI) | Common | 74587V107 | $31.6K | 711,800 | 0.1% |
| Perrigo Company | Common | 714290103 | $24.5K | 202,607 | 0.0% |
| Onyx Pharmaceuticals, Inc. | Common | 683399109 | $22.0K | 253,856 | 0.0% |
| Amgen, Inc.(AMGN) | Common | 031162100 | $19.7K | 200,143 | 0.0% |
| Warner Chilcott plc | Shares A | G94368100 | $15.6K | 782,797 | 0.0% |
| Mylan, Inc. | Common | 628530107 | $15.1K | 488,209 | 0.0% |
| Shire plc | Sponsored ADR | 82481R106 | $14.7K | 154,153 | 0.0% |
| Merck & Co., Inc.(MRK) | Common | 58933Y105 | $13.8K | 296,620 | 0.0% |
| Cubist Pharmaceuticals, Inc. | Common | 229678107 | $12.8K | 265,972 | 0.0% |
| Akorn, Inc.(AKRXEUR) | Common | 009728106 | $12.7K | 935,758 | 0.0% |
| Aetna, Inc. | Common | 00817Y108 | $12.5K | 197,241 | 0.0% |
| Verastem, Inc. | Common | 92337C104 | $12.3K | 884,920 | 0.0% |
| Teva Pharmaceutical Industries Ltd.(TEVA) | ADR | 881624209 | $12.2K | 311,476 | 0.0% |
| Actavis, Inc. | Common | 00507K103 | $11.5K | 91,500 | 0.0% |
| Hologic, Inc.(HOLX) | Common | 436440101 | $11.4K | 592,915 | 0.0% |
| Medivation, Inc. | Common | 58501N101 | $10.2K | 206,439 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | Common | 64125C109 | $9.5K | 707,990 | 0.0% |
| Incyte Corporation(INCY) | Common | 45337C102 | $9.3K | 421,300 | 0.0% |
| Questcor Pharmaceuticals, Inc. | Common | 74835Y101 | $7.9K | 173,928 | 0.0% |
| Amarin Corporation plc | Sponsored ADR | 023111206 | $7.9K | 1,362,298 | 0.0% |
| Allergan, Inc. | Common | 018490102 | $7.8K | 93,077 | 0.0% |
| Illumina, Inc.(ILMN) | Common | 452327109 | $7.8K | 103,841 | 0.0% |
| Alere, Inc. | Common | 01449J105 | $7.8K | 316,553 | 0.0% |
| Ironwood Pharmaceuticals, Inc.(IRWD) | Common | 46333X108 | $7.6K | 768,050 | 0.0% |
| Ariad Pharmaceuticals, Inc. | Common | 04033A100 | $7.2K | 412,965 | 0.0% |
| Impax Laboratories, Inc. | Common | 45256B101 | $6.9K | 344,683 | 0.0% |
| Immunogen, Inc.(IMGNEUR) | Common | 45253H101 | $6.5K | 393,773 | 0.0% |
| McKesson Corporation(MCK) | Common | 58155Q103 | $6.5K | 56,862 | 0.0% |
| Forest Laboratories, Inc. | Common | 345838106 | $6.0K | 146,500 | 0.0% |
| Sagent Pharmaceuticals, Inc. | Common | 786692103 | $5.7K | 270,031 | 0.0% |
| Alkermes plc(ALKS) | Shares | G01767105 | $5.6K | 194,870 | 0.0% |
| UnitedHealth Group, Inc.(UNH) | Common | 91324P102 | $5.4K | 82,436 | 0.0% |
| Baxter International, Inc.(BAX) | Common | 071813109 | $5.4K | 77,675 | 0.0% |
| Idexx Laboratories, Inc.(IDXX) | Common | 45168D104 | $5.1K | 56,265 | 0.0% |
| Endo Pharmaceutical Holdings, Inc. | Common | 29264F205 | $4.6K | 126,215 | 0.0% |
| CVS Caremark Corporation(CVS) | Common | 126650100 | $4.1K | 71,591 | 0.0% |
| Acorda Therapeutics, Inc. | Common | 00484M106 | $3.7K | 112,881 | 0.0% |
| Merrimack Pharmaceuticals Inc. | Common | 590328100 | $3.6K | 537,600 | 0.0% |
| Elan Corporation plc | ADR | 284131208 | $3.4K | 242,500 | 0.0% |
| IntelliPharmaCeutics International, Inc. | Common | 458173101 | $2.8K | 1,735,000 | 0.0% |
| Rigel Pharmaceuticals, Inc.(RIGLUSD) | Common | 766559603 | $2.8K | 827,100 | 0.0% |
| Auxilium Pharmaceuticals, Inc. | Common | 05334D107 | $2.1K | 127,520 | 0.0% |